OI Ljubljana
Eng

Reprezentativne publikacije

Celotna bilbiografija oddelka je dostopna na: https://www.ncbi.nlm.nih.gov/sites/myncbi/163TBPN_JdWQG/collections/54902766/public/

2018

2017

2016

2015

2014

  • Miklavcic D., Mali B., Kos B., Heller R., Sersa G. Electrochemotherapy: from the drawing board into medical practice. Biomed Eng Online, 2014; 13: 1-29. [PubMed: 24621079]
  • Blagus T., Zager V., Cemazar M., Kotnik T., Sersa G., Kamensek U., Nunic J., Filipic M. A cell-based biosensor system HepG2CDKN1A-DsRed for rapid and simple detection of genotoxic agents. Biosensors & Bioelectronics, 2014; 61: 102-111. [PubMed: 24861570]
  • Yarmush M.L., Golberg A., Sersa G., Kotnik T., Miklavcic D. Electroporation-Based Technologies for Medicine: Principles, Applications, and Challenges. Annu Rev Biomed Eng, 2014; 16: 295-320. [PubMed: 24905876]
  • Edhemovic I., Brecelj E., Gasljevic G., Marolt Music M., Gorjup V., Mali B., Jarm T., Kos B., Pavliha D., Grcar Kuzmanov B., Cemazar M., Snoj M., Miklavcic D., Gadzijev E. M., Sersa G. Intraoperative Electrochemotherapy of Colorectal Liver Metastases. J Surg Oncol, 2014; 110: 320-327. [PubMed: 24782355]
  • Prosen L., Markelc B., Dolinsek T., Music M., Cemazar M., Sersa G. Mcam Silencing With RNA Interference Using Magnetofection has Antitumor Effect in Murine Melanoma. Mol Imaging Biol, 2014; 3: 1-14. [PubMed: 25350580]

2013

  • Sedlar A., Kranjc S., Dolinsek T., Cemazar M., Coer A., Sersa G. Radiosensitizing effect of intratumoral interleukin-12 gene electrotransfer in murine sarcoma. BMC Cancer, 2013; 13 (38): 1-11. [PubMed: 23360213]
  • Todorovic V., Sersa G., Cemazar M. Gene electrotransfer of siRNAs against CD146 inhibits migration and invasion of human malignant melanoma cells SK-MEL28. Cancer Gene Ther, 2013; 20(3): 208-10. [PubMed: 23370332]
  • Dolinsek T., Markelc B., Sersa G., Coer A., Stimac M., Lavrencak J., Brozic A., Kranjc S., Cemazar M. Multiple Delivery of siRNA against Endoglin into Murine Mammary Adenocarcinoma Prevents Angiogenesis and Delays Tumor Growth. PLOS ONE, 2013; 8(3): e58723. [PubMed: 23593103]
  • Tesic N., Cemazar M. In vitro targeted gene electrotransfer to endothelialcells withplasmid DNA containing human endothelin-1 promoter. J Membr Biol, 2013; 246(10): 783-91. [PubMed: 23652810]
  • Bosnjak M., Prosen L., Dolinsek T., Blagus T., Markelc B., Cemazar M., Bouquet C., Sersa G. Biological properties of melanoma and endothelial cells afterplasmid AMEP gene electrotransfer depend on integrin quantity on cells. J Membr Biol, 2013; 246(11): 803-19. [PubMed: 23649038]
  • Kamensek U., Sersa G., Cemazar M. Evaluation of p21 promoter for interleukin 12 radiation induced  transcriptional targeting in a mouse tumor model. Mol Cancer  , 2013; 12(136): 1-12. [PubMed: 24219565]
  • Spanggaard I., Snoj M., Cavalcanti A., Bouquet C., Sersa G., Robert C., Cemazar M., Dam E., Vasseur B., Attali P., Mir L.M., Gehl J. Gene electrotransfer of plasmid antiangiogenic metargidin peptide (AMEP) in disseminated melanoma: safety and efficacy results of a phase I first-in-man study. Human Gene Ther Clin Developme, 2013; 24: 99-107.[PubMed: 23980876]
  • Prosen L., Prijic S., Music M., Lavrencak J., Cemazar M., Sersa G. Magnetofection: a reproducible method for gene delivery to melanoma cells. Biomed Res Int, 2013; 2013: 209452. [PubMed: 23862136]
  • Markelc B., Sersa G., Cemazar M. Differential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vessels. PLOS ONE, 2013; 8(3): e59557. [PubMed: 23555705]
  • Blagus T., Markelc B., Cemazar M., Kosjek T., Preat V., Miklavcic D., Sersa G. In vivo real-time monitoring system of electroporation mediated control of transdermal and topical drug delivery. J Control Release, 2013; 172(3): 862-871. [PubMed: 24113487]
  • Todorovic V., Kamensek U., Sersa G., Cemazar M. Changing electrode orientation, but not pulse polarity, increases the efficacy of gene electrotransfer to tumors in vivo. Bioelectrochemistry, 2013; BIOJEC-06714: 1-9.

2012

  • Prijic S., Prosen L., Cemazar M., Scancar J., Romih R., Lavrencak J., Bregar V. B., Coer A., Krzan M., Znidarsic A., Sersa G. Surface modified magnetic nanoparticles for immuno-gene therapy of murine mammary adenocarcinoma.Biomaterials, 2012; 33: 4379-4391. [PubMed: 22429983]
  • Markelc B., Bellard E., Sersa G., Pelofy S., Teissie J., Coer A., Golzio M., Cemazar M. In vivo molecular imaging and histological analysis of changes induced by electric pulses used for plasmid DNA electrotransfer to the skin: a study in a dorsal window chamber in mice. J Membr Biol, 2012; 245(9): 545-54. [PubMed: 22644389]
  • Miklavcic D., Sersa G., Brecelj E., Gehl J., Soden D., Bianchi G., Ruggieri P., Rossi C.R., Campana L.G., Jarm T. Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors.Med Biol Eng Comp, 2012; 50: 1213-1225. [PubMed: 23179413]

2011

  • Kamensek U., Sersa G., Mesojednik S., Tevz G., Kranjc S., Cemazar M. Irradiation, cisplatin, and 5-Azacytidine upregulate cytomegalovirus promoter in tumors and muscles: implementation of non-invasive fluorescence imaging.Mol Imaging Biol, 2011. 13: 43-52. [PubMed: 20396957]
  • Sersa G., Gehl J., Garbay J.R., Soden D., O`Sullivan G.C., Matthiessen L.V., Snoj M., Mir L.M. Electrochemotherapy of Small Tumors; The Experience from the ESOPE (European Standard Operating Procedures for Electrochemotherapy) Group. Clinical Aspects of Electropor, 2011; 8: 93-102.
  • Sersa G., Cemazar M. Vascular-Disrupting Action of Electrochemotherapy: Mode of Action and Therapeutic Implications.Clinical Aspects of Electropor, 2011; 7: 83-91.

2010

  • Cemazar M., Jarm T., Sersa G. Cancer electrogene therapy with interleukin-12. Curr Gene Ther, 2010; 10: 300-311. [PubMed: 20560875]
  • Jarm T., Cemazar M., Miklavcic D., Sersa G. Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. Expert Rev Anticancer Ther, 2010; 10(5): 729-746. [PubMed: 20470005]
  • Miklavcic D., Snoj M., Zupanic A., Kos B., Cemazar M., Kropivnik M., Bracko M., Pecnik T., Gadzijev E. M., Sersa G. Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy.Biomed Eng Online, 2010; 9: 10. [PubMed: 20178589]

2009

  • Kranjc S., Tevz G., Kamensek U., Mesojednik S., Cemazar M., Sersa G. Radiosensitizing effect of electrochemotherapy in a fractionated radiation regimen in radiosensitive murine sarcoma and radioresistant adenocarcinoma tumor model.Radiat Res, 2009; 172: 677-685. [PubMed: 19929414]
  • Tevz G., Kranjc S., Cemazar M., Kamensek U., Coer A., Krzan M., Mesojednik S., Pavlin D., Sersa G. Controlled systemic release of interleukin-12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas.J Gene Med, 2009; 11: 1125-1137. [PubMed: 19777440]

2008

  • Sersa G., Miklavic D., Cemazar M, Rudolf Z., Pucihar G., Snoj M. Electrochemotherapy in treatment of tumours.Eur J Surg Oncol, 2008; 34(2): 232-240. [PubMed: 17614247]
  • Sersa G., Jarm T., Kotnik T., Coer A., Podkrajšek M., Sentjurc M., Miklavcic D., Kadivec M., Kranjc S., Semrov D., Cemazar M. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma.Brit J Cancer, 2008; 98(2): 388-398. [PubMed: 18182988]
  • Sersa G., Miklavcic D. Electrochemotherapy of tumours.J Vis Exp, 2008; 22: 1038. [PubMed: 19370177]
  • Cemazar M., Tamzali Y., Sersa G., Tozon N., Mir L.M., Miklavcic D., Lowe R., Teissie J. Electrochemotherapy in veterinary oncology.J Vet Intern Med, 2008; 22(49): 826-831. [PubMed: 18537879]

2007

  • Cemazar M., Sersa G. Electrotransfer of therapeutic molecules into tissues.Curr Opin Mol Ther, 2007; 9(6): 554-562. [PubMed: 18041666]

 

 

© 2018 - Onkološki inštitut Ljubljana